The Impact of Strict Public Health Restrictions on Pediatric Critical Illness

Aline B Maddux1,2, Kristen Campbell1, Alan G Woodruff3

  • 1Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO.

Insights

Public health interventions significantly reduced pediatric intensive care unit (PICU) admissions, particularly for respiratory and infectious illnesses in young children. These findings highlight the potential for public health strategies to prevent critical pediatric illnesses.

Area of Science:

  • Pediatric critical care medicine
  • Public health policy
  • Epidemiology

Background:

  • Public health interventions, such as stay-at-home orders, were implemented globally in response to the COVID-19 pandemic.
  • The impact of these interventions on pediatric critical care admissions was not well characterized.

Purpose of the Study:

  • To analyze the effect of public health interventions on the volume and characteristics of pediatric intensive care unit (PICU) admissions.
  • To compare PICU admissions during stay-at-home orders with pre-pandemic baseline data.

Main Methods:

  • A multicenter retrospective cohort study was conducted across six U.S. referral PICUs.
  • Data from February 15, 2020, to May 14, 2020, were compared to the same period in 2017-2019.
  • Generalized linear mixed modeling was used to compare patient and admission characteristics.

Main Results:

  • A significant reduction in daily PICU admissions and patient days was observed during the stay-at-home order period compared to baseline (p < 0.001).
  • Admissions were less common for young children and for respiratory and infectious illnesses, but more common for poisonings and endocrinopathies.
  • No significant differences were found in hospitalization characteristics, except for a decrease in noninvasive ventilation use.

Conclusions:

  • The observed reductions in PICU admissions suggest that many cases of pediatric critical illness, especially in younger children and those with respiratory or infectious conditions, may be preventable.
  • Targeted public health strategies could play a crucial role in reducing the burden of pediatric critical illness.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
48
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
44
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
46
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K